fashion -WSS

fashion

author：leisure time 2025-09-29 21:24:05 - browse：6

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Head of FDA's diagnostics center, who led through Covid, retires

explore

WSS

Future doctors need a strong humanities education

Ending racial health disparities hinges on penalties, political will

EF3 tornado rips through North Carolina amid extreme weather nationwide

HPV vaccine, cervical cancer study delivers historic results

Mass General totes up its waste in a move to tackle climate change

Texas Department of Public Safety speaks out on migrant abuse allegations

focus

fashion

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Awakening the world to the whoosh: A patient's crusade

The cancer drug shortage isn’t new — and neither are the solutions

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Affirmative action in medical school literally saved lives

Affordable Connectivity Program vital to health care, experts say

Walensky prepares to leave CDC — and Congress — behind

FDA sets aggressive timeline for overhauling inspection procedures

Drug repurposing or repositioning? The language matters

Microsoft launches AI tool for clinical documentation through Epic

Wikipedia

TikTok, Instagram influencers need more rules for drug ads

TikTok, Instagram influencers need more rules for drug ads

Update the Apgar Score to remove skin color

CVS is on a mission to consolidate health care. Will it work?

Vir antibody drug aimed at influenza A fails in clinical trial

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

leisure time

focus

explore

knowledge